Back to Results
First PageMeta Content



Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano
Add to Reading List

Document Date: 2016-10-24 01:27:48


Open Document

File Size: 325,90 KB

Share Result on Facebook
UPDATE